Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies

Vaccine

Volumn 29, Issue 18, 2011, Pages 3424-3430

  Rimmelzwaan, Guus F ^a,b   Joyce Verburgh, R ^a   Nieuwkoop, Nella J ^a   Bestebroer, Theo M ^a   Fouchier, Ron A M ^a   Osterhaus, Albert D M E ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Viroclinics Biosciences BV   (Netherlands)

Author keywords

H5N1; Influenza virus; Serology

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANTIGENICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; VIRUS DETECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; DOGS; FERRETS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE SERA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; RABBITS; SHEEP;

EID: 79954735904     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.082     Document Type: Article

References (20)

1. World Health Organization. Global Alert and Response (GAR): Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. Accessed April 21, 2010 [cited 2010; Available from: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_12_09/en/index.html.
2. Kreijtz J.H., Osterhaus A.D., Rimmelzwaan G.F. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control. Hum Vaccin 2009, 5(March (3)):126-135.
3. de Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003, 115:63-73.
4. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37(April (4)):937-943.
5. Stephenson I., Wood J.M., Nicholson K.G., Zambon M.C. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol 2003, 70(July (3)):391-398.
6. Rimmelzwaan G.F., Nieuwkoop N.J., de Mutsert G., Boon A.C., Kuiken T., Fouchier R.A., et al. Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry. Virus Res 2007, 129(November (2)):175-181.
7. Rimmelzwaan G.F., Baars M., Claas E.C., Osterhaus A.D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 1998, 74(September (1)):57-66.
8. de Wit E., Spronken M.I., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res 2004, 103(July (1-2)):155-161.
9. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 2000, 97(May (11)):6108-6113.
10. Fujii Y., Goto H., Watanabe T., Yoshida T., Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 2003, 100(February (4)):2002-2007.
11. Masurel N., Ophof P., de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg (Lond) 1981, 87(October (2)):201-209.
12. Palmer D.F., Dowdle W.R., Coleman M.T., Schild G.C. Haemagglutination inhibition test 1975, US Dept. Health, Education, and Welfare, Atlanta.
13. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009, 15(August (8)):1252-1259.
14. Nefkens I., Garcia J.M., Ling C.S., Lagarde N., Nicholls J., Tang D.J., et al. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 2007, 39(May (1)):27-33.
15. Yang Z.Y., Wei C.J., Kong W.P., Wu L., Xu L., Smith D.F., et al. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 2007, 317(August (5839)):825-828.
16. Martinez-Sobrido L., Cadagan R., Steel J., Basler C.F., Palese P., Moran T.M., et al. Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol 2010, 84(February (4)):2157-2163.
17. Hossain M.J., Perez S., Guo Z., Chen L.M., Donis R.O. Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays. J Clin Microbiol 2010, 48(July (7)):2515-2523.
18. Lutz A., Dyall J., Olivo P.D., Pekosz A. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods 2005, 126(June (1-2)):13-20.
19. Li Y., Larrimer A., Curtiss T., Kim J., Jones A., Baird-Tomlinson H., et al. Influenza virus assays based on virus-inducible reporter cell lines. Influenza Other Respi Viruses 2009, 3(5):241-251.
20. Philippa J., Baas C., Beyer W., Bestebroer T., Fouchier R., Smith D., et al. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 2007, 25(May (19)):3800-3808.